David Stanton
Stock Analyst at Jefferies
(4.13)
# 1,607
Out of 5,081 analysts
251
Total ratings
43.6%
Success rate
10.7%
Average return
Main Sectors:
Stocks Rated by David Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: SIG Sigma Healthcare Limited | Reiterated: Buy | $3.20 → $3.15 | $2.73 | +15.60% | 19 | Oct 21, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $32.00 → $31.50 | $12.80 | +146.09% | 27 | Oct 21, 2026 | |
| ASX: PME Pro Medicus Limited | Reiterated: Hold | $196.95 → $199.00 | $196.32 | +1.37% | 7 | Oct 20, 2026 | |
| ASX: MSB Mesoblast Limited | Reiterated: Buy | $2.90 → $2.80 | $1.80 | +55.56% | 18 | Oct 16, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Reiterated: Hold | $48.50 → $49.85 | $54.84 | -9.10% | 14 | Oct 13, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Hold | $146.50 → $161.50 | $195.03 | -17.19% | 26 | Oct 6, 2026 | |
| ASX: HLS Healius Limited | Reiterated: Hold | $0.41 → $0.44 | $0.44 | +1.15% | 19 | Sep 25, 2026 | |
| ASX: IMM Immutep Limited | Upgraded: Buy | $0.04 → $0.08 | $0.02 | +247.83% | 9 | Sep 15, 2026 | |
| ASX: MVF Monash IVF Group Limited | Reiterated: Buy | $0.83 → $0.80 | $0.71 | +12.28% | 12 | Sep 1, 2026 | |
| ASX: CUV Clinuvel Pharmaceuticals Limited | Reiterated: Buy | $40.80 → $39.30 | $7.10 | +453.52% | 12 | Aug 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.50 → $3.30 | $2.10 | +57.52% | 11 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29.40 → $28.90 | $18.71 | +54.46% | 19 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $128.40 → $144.75 | $138.78 | +4.30% | 20 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23.00 → $21.00 | $18.91 | +11.05% | 22 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.00 → $5.60 | $1.58 | +254.43% | 12 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $12.39 | n/a | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.30 | n/a | 3 | Apr 8, 2021 |
Sigma Healthcare Limited
Oct 21, 2026
Reiterated: Buy
Price Target: $3.20 → $3.15
Current: $2.73
Upside: +15.60%
Telix Pharmaceuticals Limited
Oct 21, 2026
Reiterated: Buy
Price Target: $32.00 → $31.50
Current: $12.80
Upside: +146.09%
Pro Medicus Limited
Oct 20, 2026
Reiterated: Hold
Price Target: $196.95 → $199.00
Current: $196.32
Upside: +1.37%
Mesoblast Limited
Oct 16, 2026
Reiterated: Buy
Price Target: $2.90 → $2.80
Current: $1.80
Upside: +55.56%
Ramsay Health Care Limited
Oct 13, 2026
Reiterated: Hold
Price Target: $48.50 → $49.85
Current: $54.84
Upside: -9.10%
CSL Limited
Oct 6, 2026
Reiterated: Hold
Price Target: $146.50 → $161.50
Current: $195.03
Upside: -17.19%
Healius Limited
Sep 25, 2026
Reiterated: Hold
Price Target: $0.41 → $0.44
Current: $0.44
Upside: +1.15%
Immutep Limited
Sep 15, 2026
Upgraded: Buy
Price Target: $0.04 → $0.08
Current: $0.02
Upside: +247.83%
Monash IVF Group Limited
Sep 1, 2026
Reiterated: Buy
Price Target: $0.83 → $0.80
Current: $0.71
Upside: +12.28%
Clinuvel Pharmaceuticals Limited
Aug 30, 2026
Reiterated: Buy
Price Target: $40.80 → $39.30
Current: $7.10
Upside: +453.52%
Aug 27, 2026
Reiterated: Buy
Price Target: $3.50 → $3.30
Current: $2.10
Upside: +57.52%
Aug 27, 2026
Reiterated: Buy
Price Target: $29.40 → $28.90
Current: $18.71
Upside: +54.46%
Aug 20, 2026
Reiterated: Hold
Price Target: $128.40 → $144.75
Current: $138.78
Upside: +4.30%
Aug 20, 2026
Reiterated: Hold
Price Target: $23.00 → $21.00
Current: $18.91
Upside: +11.05%
Jul 28, 2026
Reiterated: Buy
Price Target: $5.00 → $5.60
Current: $1.58
Upside: +254.43%
Dec 6, 2022
Downgraded: Hold
Price Target: n/a
Current: $12.39
Upside: n/a
Apr 8, 2021
Downgraded: Hold
Price Target: n/a
Current: $13.30
Upside: n/a